120 related articles for article (PubMed ID: 29858389)
1. Enhancement of 5-Fluorouracil Cytotoxicity by Pyridoxal 5'-Phosphate and Folinic Acid in Tandem.
Machover D; Goldschmidt E; Mollicone R; Haghighi-Rad F; Desterke C; Gaston-Mathé Y; Saffroy R; Boucheix C; Dairou J
J Pharmacol Exp Ther; 2018 Aug; 366(2):238-243. PubMed ID: 29858389
[TBL] [Abstract][Full Text] [Related]
2. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Morton CL; Adkins DA; Rahman A
Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic synergism of methioninase in combination with 5-fluorouracil and folinic acid.
Machover D; Zittoun J; Broët P; Metzger G; Orrico M; Goldschmidt E; Schilf A; Tonetti C; Tan Y; Delmas-Marsalet B; Luccioni C; Falissard B; Hoffman RM
Biochem Pharmacol; 2001 Apr; 61(7):867-76. PubMed ID: 11274973
[TBL] [Abstract][Full Text] [Related]
4. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells.
Tillman DM; Petak I; Houghton JA
Clin Cancer Res; 1999 Feb; 5(2):425-30. PubMed ID: 10037193
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacologic basis for potentiation of 5-fluorouracil action by leucovorin.
Rustum YM; Trave F; Zakrzewski SF; Petrelli N; Herrera L; Mittelman A; Arbuck SG; Creaven PJ
NCI Monogr; 1987; (5):165-70. PubMed ID: 2448653
[TBL] [Abstract][Full Text] [Related]
6. Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.
Moran RG; Scanlon KL
Cancer Res; 1991 Sep; 51(17):4618-23. PubMed ID: 1831402
[TBL] [Abstract][Full Text] [Related]
7. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells.
Keyomarsi K; Moran RG
Cancer Res; 1986 Oct; 46(10):5229-35. PubMed ID: 2944577
[TBL] [Abstract][Full Text] [Related]
8. Influence of dose of [6RS]leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts.
Houghton JA; Williams LG; Cheshire PJ; Wainer IW; Jadaud P; Houghton PJ
Cancer Res; 1990 Jul; 50(13):3940-6. PubMed ID: 2354443
[TBL] [Abstract][Full Text] [Related]
9. Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts.
Houghton JA; Williams LG; Loftin SK; Cheshire PJ; Morton CL; Houghton PJ; Dayan A; Jolivet J
Cancer Chemother Pharmacol; 1992; 30(6):423-32. PubMed ID: 1394798
[TBL] [Abstract][Full Text] [Related]
10. Lack of enhanced cytotoxicity of cultured L1210 cells using folinic acid in combination with sequential methotrexate and fluorouracil.
Danhauser LL; Heimer R; Cadman E
Cancer Chemother Pharmacol; 1985; 15(3):214-9. PubMed ID: 3876889
[TBL] [Abstract][Full Text] [Related]
11. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
Matsuoka H; Furusawa M; Tomoda H; Seo Y; Sugimachi K
Anticancer Res; 1993; 13(6A):2201-6. PubMed ID: 8297134
[TBL] [Abstract][Full Text] [Related]
12. Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells.
Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P; Bertino JR
Biochem Pharmacol; 1987 Sep; 36(18):2905-11. PubMed ID: 2958010
[TBL] [Abstract][Full Text] [Related]
13. Synergistic cytotoxic effect between serine-threonine phosphatase inhibitors and 5-fluorouracil: a novel concept for modulation of cytotoxic effect.
Islam MM; Begum S; Lin L; Okamura A; Du M; Fujimura S
Cancer Chemother Pharmacol; 2002 Feb; 49(2):111-8. PubMed ID: 11862424
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the antitumor effects of 5-fluorouracil by folinic acid.
Mini E; Trave F; Rustum YM; Bertino JR
Pharmacol Ther; 1990; 47(1):1-19. PubMed ID: 2195551
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic modulation of 5-fluorouracil by folinic acid and pyridoxine for treatment of patients with advanced breast carcinoma.
Machover D; Goldschmidt E; Almohamad W; Castagné V; Dairou J; Desterke C; Gomez L; Gaston-Mathé Y; Boucheix C
Sci Rep; 2022 May; 12(1):9079. PubMed ID: 35641554
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic modulation of 5-fluorouracil by folinic acid and high-dose pyridoxine for treatment of patients with digestive tract carcinomas.
Machover D; Almohamad W; Castagné V; Desterke C; Gomez L; Gaston-Mathé Y; Boucheix C; Goldschmidt E
Sci Rep; 2021 Jun; 11(1):12668. PubMed ID: 34135415
[TBL] [Abstract][Full Text] [Related]
17. Interaction between 5-fluorouracil, [6RS]leucovorin, and recombinant human interferon-alpha 2a in cultured colon adenocarcinoma cells.
Houghton JA; Adkins DA; Rahman A; Houghton PJ
Cancer Commun; 1991 Jul; 3(7):225-31. PubMed ID: 1867955
[TBL] [Abstract][Full Text] [Related]
18. Dual modulation of 5-fluorouracil cytotoxicity using folinic acid with a dihydropyrimidine dehydrogenase inhibitor.
Fischel JL; Formento P; Etienne MC; Spector T; Renée N; Milano G
Biochem Pharmacol; 1997 Jun; 53(11):1703-9. PubMed ID: 9264323
[TBL] [Abstract][Full Text] [Related]
19. Combination cytotoxic effects of cis-diamminedichloroplatinum(II) and 5-fluorouracil with and without leucovorin against human non-small cell lung cancer cell lines.
Tsai CM; Hsiao SH; Frey CM; Chang KT; Perng RP; Gazdar AF; Kramer BS
Cancer Res; 1993 Mar; 53(5):1079-84. PubMed ID: 8382553
[TBL] [Abstract][Full Text] [Related]
20. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]